; on behalf of the RCMI Investigators and RTRN Team Members
The Research Centers in Minority Institutions (RCMI) program was established by the US Congress to support the development of biomedical research infrastructure at minority-serving institutions granting doctoral degrees in the health professions or in a health-related science. RCMI institutions also conduct research on diseases that disproportionately affect racial and ethnic minorities (ie, African Americans/Blacks, American Indians and Alaska Natives, Hispanics, Native Hawaiians and Other Pacific Islanders), those of low socioeconomic status, and rural persons. Quantitative metrics, including the numbers of doctoral science degrees granted to underrepresented students, NIH peer-reviewed research funding, peer-reviewed publications, and numbers of racial and ethnic minorities participating in sponsored research, demonstrate that RCMI grantee institutions have made substantial progress toward the intent of the Congressional legislation, as well as the NIH/NIMHD-linked goals of addressing workforce diversity and health disparities. Despite this progress, nationally, many challenges remain, including persistent disparities in research and career development awards to minority investigators. The continuing underrepresentation of minority investigators in NIH-sponsored research across multiple disease areas is of concern, in the face of unrelenting national health inequities. With the collaborative network support by the RCMI Translational Research Network (RTRN), the RCMI community is uniquely positioned to address these challenges through its community engagement and strategic partnerships with non-RCMI institutions. Funding agencies can play an important role by incentivizing such collaborations, and incorporating metrics for research funding that address underrepresented populations, workforce diversity and health equity. Ethn Dis. 2019;29(SupplRCMI Network -Ofili et al potential of a diverse workforce to improve health care access, increase patient satisfaction, and ensure culturally competent care by adequately addressing social determinants that impact health during medical interactions with patients. 2 The central role of the Research Centers in Minority Institutions (RCMI) consortium in addressing National Institutes of Health (NIH)-linked objectives of a diverse workforce and health equity was highlighted in three keynote presentations delivered at the RCMI Translational Science 2017 Conference in Washingpal deputy director, called attention to the importance of RCMI grantee institutions in the nation's biomedical research and workforce diversity, stating, "everything about RCMI is embedded in the strategic plan of NIH". 5 This article presents data on the impact of the RCMI program and the RCMI Translational Research Network (RTRN). The historical context of the RCMI program and its impact on NIH priorities is relevant to the network's value as a strategic partner in addressing current challenges in workforce diversity and health equity.
HIstory of tHe rcMI PrograM
The RCMI program was established in 1985 in response to committee report language (House Report 98-911) attached to H.R. 6028, the Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriation Act, 1985, to "establish research centers in those predominantly minority institutions which offer doctoral degrees in the health professions or the sciences related to health." 6 Subsequent legislation (H.R. 3010) upheld and further recognized the critical role played by the RCMI program and encouraged NIH to strengthen participation from minority institutions and resources available for this area.
Through the original legislation that established the RCMI program in 1985, NIH moved to strengthen the research environment in predominantly minority institutions by providing funds to: "1) develop and enhance the institutional research infrastructure necessary for the conduct of biomedical and/or behavioral research; 2) enable minority institutions to become more successful in obtaining competitive extramural support for the conduct of biomedical and/or behavioral research; and 3) enhance the biomedical research environment at these institutions." To accomplish this, at least two-thirds of the requested funds were expected to be directed to build multi-user resources, rather than to support individual research projects. Thus, research infrastructure is central to the legislative intent of the RCMI program.
desIgn of tHe rcMI PrograM

RCMI Research Infrastructure and Research Development
The National Center for Research Resources (NCRR) at NIH served as the administrative home of the RCMI program, which evolved from its initial focus on providing infrastructure solely for basic biomedical research. In the mid-1990s, the focus was expanded to include the development of infrastructure to increase research capacity for clinical research, and in 2002-2003 infrastructure for community-based research. The RCMI program at NCRR also administered a trans-NIH-funded Clinical Research Education and Career Development (CRECD) program supported through an R25 mechanism. Figure 1 shows the timeline and mechanisms of RCMI funding. Regardless of the mechanism, all RCMI awards were …investigator diversity still falls far short of mirroring that of the US population. 10, 11 ton, DC. During the opening plenary keynote, NIH Director Dr. Francis S. Collins, stated, "we look to the RCMI community as the brain trust to help develop novel solutions on health disparities". 3 During his plenary address, Dr. Eliseo Pérez-Stable, director of the National Institute on Minority Health and Health Disparities (NIMHD), underscored the importance of addressing the levels of influence from the individual to the societal level, across the various domains of influence from the biological to the sociocultural environment and indeed beyond, to the health care system. 4 At the closing plenary, Dr. Lawrence A. Tabak 
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nities impacted by high disease burden and poor access to health care. RTRN leverages the scientific expertise, technologies and innovations of its RCMI minority-serving research institutions to accelerate the delivery of solutions to address critical health problems, particularly health disparities.
The network is governed by a steering committee, which has representation from RCMI and non-RCMI grantee institutions, industry collaborators, and community partners. The steering committee develops and ratifies policies for network activities, such as data sharing and IRB harmonization. The Network has six steering subcommittees, which are responsible for optimizing resource utilization: The NIH has long recognized that achieving diversity in the biomedical and behavioral research workforce is critical to ensuring that the best and brightest minds have the opportunity to contribute to the achievement of our national research goals. Despite longstanding efforts from the NIH and other entities across the biomedical and behavioral research landscape to increase the number of scientists from underrepresented groups, investigator diversity still falls far short of mirroring that of the US population. 10, 11 Additionally, a disturbing discrepancy in success rates for research grant (R01) applications between White and Black applicants, even after controlling for numerous observable variables, was reported in 2011 by Ginther and colleagues. 11 Marked differences in funding success were also observed depending upon the institution from which an applicant submitted their application. Applications from the 30 most highly NIH-funded institutions had a higher probability of funding than those from institutions ranked 31 to 200. In turn, applications from the 31 to 200 institutions were more likely to be funded than those from institutions ranked 201 and beyond. In all groups, a disparity was observed for Black applicants relative to majority applicants in the same rank group. Subsequently, to address this unacceptable status quo on minority underrepresentation in biomedical and behavioral research and other challenges cited by the Working Group on Diversity in the Biomedical Research Workforce (WGDBRW), NIH funded the Diversity Program Consortium (DPC) in 2014. This consortium includes three programs: Building Infrastructure Leading to Diversity (BUILD); 12 National Research Mentoring Network (NRMN); 13 and Coordination and Evaluation Center (CEC).
The RTRN Responds: Collecting Impact Data
Given that the RTRN addresses many of the areas of concern raised by the WGDBRW and has much to offer the BUILD, NRMN, and CEC endeavors, the RTRN and RCMI site lead investigators convened to review their collective experience as a network addressing the science of health disparities and research that provided evidence for the benefits of multi-site research, [15] [16] [17] [18] [19] [20] [21] [22] meaningful inclusion of diverse populations in research studies, 23, 24 training, [25] [26] [27] and coaching models to advance the careers of underrepresented early stage investigators. 28 During RTRN-convened meetings of RCMI, principal investigators and program directors agreed on the process and timeline for data collection to support research publications and dissemination. Meetings included regularly scheduled monthly meetings, as well as a full-day leadership research retreat. A standardized data survey was electronically administered to all 18 institutions with active RCMI awards in 2016 (Table  1) ; all 18 institutions participated in the survey. Total funding and funding periods for RCMI programs, including G12 RCMI, U54 RCTR and R25 CRECD, were obtained from the NIH RePORTER database.
In addition, RCMI-funded programs provided reports on other funding (from government, foundation, industry, etc.) leveraged by RCMI-funded programs, clinical and translational research scholars trained, research participants enrolled in protocols, and patents awarded. We used progress reports submitted to NIH for funding renewal and publications citing RCMI funding from PubMed Central. Data were collected for 2000-2015. Collaboratory) . In all, regardless of cohort, the 113 ESI trainees submitted 78 total grants; 50% of trainees submitted at least 1 grant and 26% were awarded. Most (93%) of awards went to underrepresented groups (URGs); 73% of awards went to RCMI investigators. 28 This model will support future RCMI-sponsored research development, in collaboration with NIHfunded programs, such as CTSAs.
IMPact
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RCMI Impact: Clinical Research Centers
To report impact on clinical research centers, we obtained data from the following RCMI Clinical Research Centers at RCMI grantee institutions with medical schools/health systems and active U54 awards between 2008 and 2016: Charles R. Drew University; 
dIscussIon
The RCMI program continues to substantially impact the diversity of the nation's biomedical research workforce while improving the health of minority communities and advancing knowledge in the science of health disparities. RCMI researchers are using advanced technologies to support collaborations that address cancer, cardiovascular 
conclusIon and future dIrectIons
The RCMI program has demonstrated a track record in addressing health disparities research, along with diversity and inclusion in the biomedical research workforce. RCMI investigators and institutions are uniquely positioned to address the national challenges of underrepresentation and persistent health inequities through community engagement and strategic partnerships with non-RCMI institutions. Funding agencies, like the National Heart Lung and Blood Institute (NHLBI), The National Institute of General Medical Sciences (NIGMS), National Cancer Institute (NCI), National Institute of Allergy and Infectious Diseases (NIAID), National Center for Advancing Translational Sciences (NCATS), National Institute of Neurological Disorders and Stroke (NINDS), can play an important role by supporting such collaborations. In order to advance health equity, metrics for research funding should include underrepresented populations and workforce diversity.
The RCMI consortium partners include health systems implementing innovative payment models, such as Accountable Care Organizations (ACO), 31 and population health resources such as illness registries or specimen banks. 32 RTRN is coordinating efforts to leverage these population health resources by deploying informatics tools such as i2b2, 9 that will support data science initiatives, and accelerate research on the science of health disparities. Centers:  2U54MD007602, U54MD007587,  5G12MD007579, 5U54MD007600,  G12 MD007582, 2U54 MD007586,  5U54MD007593, U54MD012393,  U54MD012388, 3G12MD007603,  3G12MD007599, G12MD007581,  5G12MD007592, U54MD007584,  5G12MD007597, 5G12MD007597,  G12MD007590, 5U54MD007585,  3G12MD007591, 5U54MD012392,  1U54MD012397, 
